Novel phosphorylcholine-containing protein of Pseudomonas aeruginosa chronic infection isolates interacts with airway epithelial cells

被引:50
作者
Barbier, Mariette [1 ]
Oliver, Antonio [1 ,3 ]
Rao, Jayasimha [4 ]
Hanna, Sheri L. [4 ]
Goldberg, Joanna B. [4 ]
Alberti, Sebastian [1 ,2 ]
机构
[1] Univ Illes Balears, Inst Univ Invest Ciencies Salut, Palma de Mallorca 07122, Spain
[2] Univ Illes Balears, Dept Biol, Area Microbiol, Palma de Mallorca 07122, Spain
[3] Hosp Univ Son Dureta, Microbiol Serv, Palma de Mallorca, Spain
[4] Univ Virginia, Charlottesville, VA USA
关键词
D O I
10.1086/525048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Pseudomonas aeruginosa undergoes phase variation in the expression of the phosphorylcholine (ChoP) epitope, a structure crucial for the virulence of several respiratory pathogens. In this study, ChoP expression analysis comparing organisms from acute and chronic infections revealed that expression of ChoP at 37 degrees C was higher among strains from chronic infections. Coimmunoprecipitation experiments and mass spectrometry analysis demonstrated that ChoP was on the protein elongation factor Tu. The presence of ChoP at the surface was confirmed by immunofluorescence and flow cytometry analysis of intact bacteria. Pretreatment of bronchial epithelial cells or mice with a platelet-activating factor receptor (PAFR) antagonist reduced adhesion and invasion of the ChoP-positive P. aeruginosa isolates. Results of this study suggest that ChoP expression may represent a novel phenotype expressed by the chronic infection isolates that could mediate P. aeruginosa colonization of the epithelial airway by means of the interaction with the PAFR.
引用
收藏
页码:465 / 473
页数:9
相关论文
共 36 条
[1]
BORDIER C, 1981, J BIOL CHEM, V256, P1604
[2]
STREPTOCOCCUS-PNEUMONIAE ANCHOR TO ACTIVATED HUMAN-CELLS BY THE RECEPTOR FOR PLATELET-ACTIVATING-FACTOR [J].
CUNDELL, DR ;
GERARD, NP ;
GERARD, C ;
IDANPAANHEIKKILA, I ;
TUOMANEN, EI .
NATURE, 1995, 377 (6548) :435-438
[3]
Elongation factor Tu and E1 β subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae [J].
Dallo, SF ;
Kannan, TR ;
Blaylock, MW ;
Baseman, JB .
MOLECULAR MICROBIOLOGY, 2002, 46 (04) :1041-1051
[4]
Lung function in bronchiectasis: The influence of Pseudomonas aeruginosa [J].
Evans, SA ;
Turner, SM ;
Bosch, BJ ;
Hardy, CC ;
Woodhead, MA .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (08) :1601-1604
[5]
Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity [J].
Fleiszig, SMJ ;
Evans, DJ ;
Do, N ;
Vallas, V ;
Shin, S ;
Mostov, KE .
INFECTION AND IMMUNITY, 1997, 65 (07) :2861-2867
[6]
Cross-reactivity of human immunoglobulin G2 recognizing phosphorylcholine and evidence for protection against major bacterial pathogens of the human respiratory tract [J].
Goldenberg, HB ;
McCool, TL ;
Weiser, JN .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (07) :1254-1263
[7]
Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia [J].
Govan, JRW ;
Deretic, V .
MICROBIOLOGICAL REVIEWS, 1996, 60 (03) :539-+
[8]
Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins [J].
Granato, D ;
Bergonzelli, GE ;
Pridmore, RD ;
Marvin, L ;
Rouvet, M ;
Corthésy-Theulaz, IE .
INFECTION AND IMMUNITY, 2004, 72 (04) :2160-2169
[9]
Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients [J].
Gutiérrez, O ;
Juan, C ;
Pérez, JL ;
Oliver, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3573-3575
[10]
Comparison of proteins expressed by Pseudomonas aeruginosa strains representing initial and chronic isolates from a cystic fibrosis patient:: an analysis by 2-D gel electrophoresis and capillary column liquid chromatography-tandem mass spectrometry [J].
Hanna, SL ;
Sherman, NE ;
Kinter, MT ;
Goldberg, JB .
MICROBIOLOGY-UK, 2000, 146 :2495-2508